Editorial Policies

Focus and Scope

Innovative Biosystems and Bioengineering is an international peer-reviewed journal that aims to publish original research articles, reviews, and short research reports in diverse fields of bioresearch including Applied Biology, Biomedicine, Biotechnology, Bioengineering, Biophysics, Bioinformatics, and Chemistry of Life. The journal involves a systems approach to integrate the scientific thought of researchers with distinct areas of expertise who works with research and technology projects in the life sciences area.

The scope of the journal encompasses:

Applied Biology: research of biological objects (acariots, prokaryotes, and eukaryotes, as well as their separate parts) at all levels of organization, aimed at creating of useful products and technologies (usage in industry, medicine, agriculture, etc.) and also intended for protection of the natural environment. The Journal publishes the best researches into biosafety and bioethics problems.

Biomedicine: development of new biomedical technologies, creation of products and technologies for the health system based on biological objects.

Biotechnology and Bioengineering: engineering implementation of biotechnology in various industries (food, pharmaceutical, light industry, agro-industrial complex, etc.); engineering implementation of environmental biotechnologies, industrial bioenergetics; processes and apparatuses of biotechnological manufactures.

Biophysics and Bioinformatics: physical processes at different levels of biosystems organization; the effect of the environment on the physics of a living organism, the transformation of energy in the body, thermodynamics; intracellular processes modeling, mathematical analysis of complex biological systems; biological cybernetics, structural and genomic bioinformatics.

Chemistry of Life: the molecular basis of life processes and their practical application; molecular structure of biomolecules, their dynamics and interaction, thermodynamics and mechanisms of chemical reactions; ways of chemicals biotransformation; chemical and physicochemical methods of analysis of living objects; biomolecular design; use of computer chemistry methods for biological systems modeling.

 

Section Policies

Статті

Checked Open Submissions Checked Indexed Checked Peer Reviewed
 

Peer Review Process

All manuscripts submitted to Innovative Biosystems and Bioengineering are read by the associate editor. Only those papers that seem most likely to meet our editorial criteria and the content of which match with the journal’s aims and scope are sent for formal review.

When assigned a new submission, the associate editor checks the one for its completeness and adherence to the Guide for AuthorsOur journal will first check the plagiarism of a manuscript by using UniCheck after it is submitted. The high level of similarity could cause the manuscript rejection (we read the whole paper and check which part is taken from other papers).

The corresponding author is notified by e-mail when the editor decides to pass a paper for review. The author is normally informed within 10 days of assignment to the associate editor.

Authors may indicate a limited number of scientists who should not review the paper. Excluded scientists must be identified by name. Authors may also suggest referees; these suggestions are often helpful, although they are not always followed.

All submitted manuscripts are sent for double-blind peer review to two expert reviewers. By policy, authors remain anonymous to the referees throughout the consideration process and referees are not identified to the authors, except at the request of the referee.

Alternative reviewers may also be invited to review the manuscript at any time. Authors will be informed when editors decide further review is required.

Typically the manuscript will be reviewed within 30 days.

The revised version is sent back to the original referees for re-review. The revised manuscript should be accompanied by a cover letter that includes a point-by-point response to referees' comments and an explanation of how the manuscript has been changed.

The final decision to recommend the manuscript for publication is taken by the editorial staff on the basis of the referees' reports. Authors of papers are notified promptly.

 

Open Access Policy

Journal Innovative Biosystems and Bioengineering is a fully open access publication. All articles are available on the internet to all readers immediately upon publication. They will be immediately and permanently free for everyone to read, download, copy, distribute, or link to the full texts of the articles, or use them for any other lawful purpose, without subscription barriers to access and without asking prior permission from the publisher or the author. We don’t charge any fees for any reader to download articles.

 

Archiving

This journal uses the LOCKSS system to create a file system distributed among the participant libraries and it allows them to create permanent archives of the journal for preservation and restoration. More information: http://www.lockss.org/lockss/Home.

 

Publication fee

Innovative Biosystems and Bioengineering is published as an "golden" open-access journal, whereby individuals anywhere in the world can read, download and share our peer-reviewed articles free of charge. Such unrestricted online access ensures that authors can have their work read by a much larger audience than is typically possible through more traditional subscription-based journals.

Article publication charge is USD 50 and will be required after the article has been accepted for publication. The submission of manuscripts and the review process are free.

Authors working in developing or low-income countries (according to the International Monetary Fund http://www.imf.org) can qualify for a partial waiver (up to 40% of the base charge).

Favorable factors for obtaining the maximum waiver are participation of young scientists (under 35 years) in the authors' team, high citation index of the authors' publications, as well as the experimental nature of the article.

Authors from Ukraine can qualify for a waiver up to 60% of the base charge.

Waivers for grant-supported publications are not considered.

Should you wish to get waiver on publication fee, please, make request when submitting the article ("Comments for the Editor").

 

Publication ethics

National Technical University of Ukraine "Igor Sikorsky Kyiv Polytechnic Institute" as the publisher of the scientific journal Innovative Biosystems and Bioengineering supports the Elsevier policy is aimed to adhering the principles of publication ethics (http://www.elsevier.com/about/publishing-guidelines/publishing-ethics) and recognizes the principles developed by the Committee on Publication Ethics (COPE). The Journal subscribes to the general criteria for publication detailed in Uniform Requirements for Manuscripts Submitted to Biomedical Journals (Vancouver Guidelines) by the International Committee of Medical Journal Editors. And furthermore, the Journal is guided by Code of Honour of the National Technical University of Ukraine “Igor Sikorsky Kyiv Polytechnic Institute”.

The journal Innovative Biosystems and Bioengineering expects that editors, authors, and reviewers will observe high standards with respect to publication ethics. We encourage our editors, authors and reviewers to work in accordance with the Code of Conduct adopted by the COPE.

In issuing the journal, we abide by the relevant laws and regulations for the protection of intellectual property rights and copyrights.

Ethical Responsibilities of Authors

Authors must adhere to high standards with respect to publication ethics, remain in good communication with the editor(s), the publisher and any co-authors. Authors should refrain from misrepresenting research results which could damage the trust in the journal, the professionalism of scientific authorship, and ultimately the entire scientific endeavor.

We consider unacceptable:

(1) Plagiarism (and self-plagiarism) in whole or in part without proper citation. All the citations should be correct. An author need to have written permission from the copyright owner for any reproduced figures or tables – exceptions exist under the fair dealing concept. An author must guarantee his submission is original, owned by the author, that no part of it has been previously published (partly or in full), and that no other agreement to publish it or a part of it is outstanding. The manuscript must not be under consideration elsewhere.

Manuscripts submitted to Innovative Biosystems and Bioengineering are screened with UniCheck anti-plagiarism software in an attempt to detect and prevent plagiarism.

(2) Falsification or fabrication of data. No data have been fabricated or manipulated (including images) to support conclusions. Fabrication, falsification or selective reporting of data with the intent to mislead or deceive is unethical, as is the theft of data or research results from others. If an author uses secondary data (datasets gathered by someone else), he need to obtain copyright clearance before data can be reproduced (exceptions exist under the fair dealing concept).

(3) Misappropriation of others’ work. All the contributors to an article are to be included and all acknowledgments should be up-to-date. An author(s) should acknowledge the work of others used in the research and cite publications that have influenced the direction and course of the study.

(4) The deliberate exclusion of information regarding financial support that would be viewed as a conflict of interest. An author should openly to disclose any conflict of interest – for example, if publication were to benefit a company or services in which the author(s) has a vested interest.

The manuscript should be approved by all co-authors and responsible authorities at the institute or organization where the work has been carried out.

In addition to being accountable for the parts of the work he or she has done, a corresponding author should be able to identify which co-authors are responsible for specific other parts of the work. In addition, authors should have confidence in the integrity of the contributions of their co-authors.

Adding and/or deleting authors at revision stage may be justifiably warranted. A letter must accompany the revised manuscript to explain the role of the added and/or deleted author(s). Further documentation may be required to support the request.

To ensure objectivity and transparency in research and to ensure that accepted principles of ethical and professional conduct have been followed, authors should include information regarding sources of funding, potential conflicts of interest (financial or non-financial), informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals.

For manuscripts reporting studies involving human subjects, statements identifying the committee approving the studies and confirming that informed consent was obtained from all subjects must appear in the Materials and Methods section. All experiments on live vertebrates or higher invertebrates must be performed in accordance with relevant institutional and national guidelines and regulations. Investigations involving humans will have been performed in accordance with the principles of Declaration of Helsinki. If the manuscript contains photos or parts of photos of patients, informed consent from each patient should be obtained. Patient’s identities and privacy should be carefully protected in the manuscript. The ARRIVE guidelines must be followed when reporting experiments on animals. The journal reserves the right to reject papers where the ethical aspects are, in the Editor's opinion, open to doubt.

When authors discover a serious error in their work, they must report this to the Managing Editor as soon as possible in order to modify the work, withdraw it, retract it, or publish a correction or erratum notice.

Allegations of unethical conduct will be discussed initially with the corresponding author. In the event of continued dispute, the matter will be referred to the author's institution and funding agencies for investigation and adjudication.

Ethical Responsibilities of Editors

The Editorial Board of Innovative Biosystems and Bioengineering should continuously work to improve the Journal.

Members of the Editorial Board are required to ensure the confidentiality of all manuscripts received and of their content until they have been accepted for publication. Editors must not share information about manuscripts, including whether they have been received and are under review, their content and status in the review process, criticism by reviewers, and their ultimate fate, to anyone other than the authors and reviewers.

In addition, no member of the Editorial Board may use data, lines of reasoning or interpretations in unpublished manuscripts for his or her own research, except with the authors’ express written consent.

Our Editors should decline to use reviewers who submit reports that are of poor quality, erroneous or disrespectful, or that are delivered after the agreed deadline.

Editors should not publish or publicize peer-reviewers’ comments without permission of the reviewer and author. Our journal policy is to blind authors to reviewer identity and comments are not signed. Due to this, identity must not be revealed to the author or anyone else without the reviewers’ expressed written permission.

Confidentiality may have to be breached if dishonesty or fraud is alleged, but editors should notify authors or reviewers if they intend to do so.

Editors should do all they can to ensure timely processing of manuscripts with the resources available to them. If editors intend to publish a manuscript, they should attempt to do so in a timely manner and any planned delays should be negotiated with the authors. If a journal has no intention of proceeding with a manuscript, editors should endeavor to reject the manuscript as soon as possible to allow authors to submit to a different journal.

Editors who make final decisions about manuscripts should recuse themselves from editorial decisions if they have conflicts of interest or relationships that pose potential conflicts related to articles under consideration. Other editorial staff members who participate in editorial decisions must provide editors with a current description of their financial interests or other conflicts (as they might relate to editorial judgments) and recuse themselves from any decisions in which a conflict of interest exists. Editorial staff must not use information gained through working with manuscripts for private gain.

Allegations of unethical conduct will be discussed initially with the Editor. In the event of continued dispute, the matter will be referred to the Editor’s institution for investigation and adjudication.

Ethical Responsibilities of Reviewers

Manuscripts submitted to the Journal are subject to mandatory peer-review. Innovative Biosystems and Bioengineering expects that reviewers will observe high standards with respect to publication ethics. 

Reviewers should only agree to review manuscripts for which they have the subject expertise required to carry out a proper assessment and which they can assess in a timely manner.

Reviewers are expected to respond promptly to requests to review and to submit reviews within the time agreed. Reviewers’ comments should be constructive, honest, and polite.

Reviewers should keep manuscripts, associated material, and the information they contain strictly confidential. Reviewers must not publicly discuss the authors’ work and appropriate authors’ ideas before the manuscript is published. Reviewers must not retain the manuscript for their personal use and should destroy paper copies of manuscripts and delete electronic copies after submitting their reviews.

Reviewers must disclose to editors any conflicts of interest that could bias their opinions of the manuscript, and should recuse themselves from reviewing specific manuscripts if the potential for bias exists. Reviewers must not use knowledge of the work they’re reviewing before its publication to further their own interests.

Reviewers should report any breach of publishing ethics they identify directly to the Editorial Office. The following may constitute a breach: plagiarism, self-plagiarism, manipulated images/photos/figures, biased reference list, duplicate publication, data from a previous publication reused without proper referencing, redundant publication, unstated conflicts of interest or funding, etc.

Allegations of unethical conduct will be discussed initially with the reviewer. In the event of continued dispute, the matter will be referred to the reviewer’s institution for investigation and adjudication.

Dealing with Allegations of Misconduct

We take seriously all possible misconduct. If an editor has concerns that a submitted article describes something that might be considered to constitute misconduct in research, publication or professional behavior, we will discuss the case in confidence among our editorial team.

If the case cannot be resolved by discussion with the author(s) and the Editor still has concerns, the case may be reported to the appropriate authorities. If, during the course of reviewing an article, an editor is alerted to possible problems (for example, fraudulent data) in another publication, the editor should immediately alert the Editor-in-Chief here: ibb@kpi.ua.

Readers that suspect misconduct in a published article are encouraged to report this to the Editor-in-Chief here: ibb@kpi.ua.

 

Self-archiving policy

Author’s Original Version

The author’s original version (submitted version) is defined as the un-refereed author version of an article. Authors may reuse the original version of the article anywhere at any time (on their own personal website and/or that of their employer and/or in free public servers of original version articles in their subject area), providing that once the article is accepted they provide a statement of acknowledgement, and that once the article has been published this acknowledgement is updated to provide details such as the volume and issue number, the Digital Object Identifier (DOI), and a link to the published article on the Journal’s website:

"This article has been accepted for publication in Innov Biosyst Bioeng."

Version of Record

The version of record (published version) is defined as a fixed version of the journal article.

Articles in the Journal are published under a CC BY licence. Authors are free to post and distribute their links anywhere including social media such as Facebook, blogs, and Twitter, as well as commercial repositories immediately upon publication. When posting, distributing or reusing articles, the journal should be clearly attributed as the original place of publication and correct citation details should be given. Authors should also deposit the URL of their published article in any repository, in addition to the PDF version. Preferably, the link should be, or include, the DOI.

The journal strongly encourages authors to deposit the version of record instead of the original version.